BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26432907)

  • 1. Cancer vaccines in the new era of cancer immunotherapy.
    Knutson KL; Mittendorf EA
    Vaccine; 2015 Dec; 33(51):7376. PubMed ID: 26432907
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer vaccines: 21st century approaches to harnessing an ancient modality to fight cancer.
    Berzofsky JA; Wood LV; Terabe M
    Expert Rev Vaccines; 2013 Oct; 12(10):1115-8. PubMed ID: 24124874
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic cancer vaccines: a long and winding road to success.
    Baxevanis CN; Papamichail M; Perez SA
    Expert Rev Vaccines; 2014 Jan; 13(1):131-44. PubMed ID: 24224539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New developments in cancer vaccines.
    Buonaguro L; Aurisicchio L; Buonaguro FM; Ciliberto G
    Expert Rev Vaccines; 2013 Oct; 12(10):1109-10. PubMed ID: 24124872
    [No Abstract]   [Full Text] [Related]  

  • 5. Challenges in the development of an autologous heat shock protein based anti-tumor vaccine.
    Reitsma DJ; Combest AJ
    Hum Vaccin Immunother; 2012 Aug; 8(8):1152-5. PubMed ID: 22854658
    [No Abstract]   [Full Text] [Related]  

  • 6. Overview of the cancer vaccine field: are we moving forward?
    Kudrin A; Hanna MG
    Hum Vaccin Immunother; 2012 Aug; 8(8):1135-40. PubMed ID: 22854670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized cancer neoantigen vaccines come of age.
    Chu Y; Liu Q; Wei J; Liu B
    Theranostics; 2018; 8(15):4238-4246. PubMed ID: 30128050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adventures of a vaccinologist entrepreneur.
    Sardesai NY
    Hum Vaccin Immunother; 2014; 10(6):1431-5. PubMed ID: 25264689
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer vaccine development represents a particularly interesting and active field.
    Ellis R; Riedmann EM
    Hum Vaccin Immunother; 2012 Aug; 8(8):1013. PubMed ID: 22914448
    [No Abstract]   [Full Text] [Related]  

  • 10. Increasing immunogenicity of cancer vaccines to improve their clinical outcome.
    Parmiani G; Cimminiello C; Maccalli C
    Expert Rev Vaccines; 2013 Oct; 12(10):1111-3. PubMed ID: 24124873
    [No Abstract]   [Full Text] [Related]  

  • 11. Prospects for the future of prostate cancer vaccines.
    Madan RA; Gulley JL
    Expert Rev Vaccines; 2016; 15(3):271-4. PubMed ID: 26560494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer vaccine adjuvants--recent clinical progress and future perspectives.
    Banday AH; Jeelani S; Hruby VJ
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):1-11. PubMed ID: 25318595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems vaccinology for cancer vaccine development.
    Petrizzo A; Tagliamonte M; Tornesello M; Buonaguro FM; Buonaguro L
    Expert Rev Vaccines; 2014 Jun; 13(6):711-9. PubMed ID: 24766452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous heat-shock protein vaccines.
    Colaco C
    Hum Vaccin Immunother; 2013 Feb; 9(2):275-6. PubMed ID: 23291947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy with autologous tumor cell vaccines for treatment of occult disease in early stage colon cancer.
    Hanna MG
    Hum Vaccin Immunother; 2012 Aug; 8(8):1156-60. PubMed ID: 22854664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Various ways to improve whole cancer cell vaccines.
    Cicchelero L; de Rooster H; Sanders NN
    Expert Rev Vaccines; 2014 Jun; 13(6):721-35. PubMed ID: 24758597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of animal models in cancer vaccine development.
    Wei WZ; Jones RF; Juhasz C; Gibson H; Veenstra J
    Vaccine; 2015 Dec; 33(51):7401-7407. PubMed ID: 26241945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter from the Editor.
    Ellis R
    Hum Vaccin Immunother; 2015; 11(10):2333. PubMed ID: 26376012
    [No Abstract]   [Full Text] [Related]  

  • 19. Repositioning therapeutic cancer vaccines in the dawning era of potent immune interventions.
    Bot A; Marincola F; Smith KA
    Expert Rev Vaccines; 2013 Oct; 12(10):1219-34. PubMed ID: 24099049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers.
    Hochnadel I; Kossatz-Boehlert U; Jedicke N; Lenzen H; Manns MP; Yevsa T
    Hum Vaccin Immunother; 2017 Dec; 13(12):2931-2952. PubMed ID: 29112462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.